President Joel S. Schuman, MD, highlights the group’s mission and vision for the future—uniting 17 working groups and over 80 stakeholders.

Loteprednol Etabonate Ophthalmic Suspension, 0.5% is bioequivalent to Lotemax(R) Ophthalmic Suspension, 0.5%, of Bausch & ...

Senior eye care experts have cautioned Nigerians against the use of breast milk and cow urine as remedies for eye infections and diseases, warning that such practices could lead to serious ...

Opus Genetics reports positive Phase 3 trial results for Phentolamine Ophthalmic Solution 0.75% in treating presbyopia.

Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 10 mL, 87,840 bottles from batch No. TZ1236, expiration date, 11/30/2025. The label for recalled Ketorolac Tromethamine Ophthalmic Solution.

Opus Genetics Announces VEGA-3 Phase 3 Trial Met its Primary Endpoint for Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia ...

Opus Genetics announced positive topline results from VEGA-3, its phase 3 trial evaluating phentolamine ophthalmic solution 0.75% for the treatment of presbyopia. VEGA-3 is the second phase 3 clinical ...

Opus Genetics suggests participants join 15 minutes in advance of the event. About Phentolamine Ophthalmic Solution 0.75% Phentolamine Ophthalmic Solution 0.75% is a non-selective alpha-1 and alpha-2 ...